Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks

Dana-Farber Cancer Institute

Status: Completed

Conditions: Prostate Cancer

Treatments: Behavioral: Standard prostate cancer information websites; Behavioral: Personal Patient Profile - Prostate (P3P)

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT01844999

12-363

2R01NR009692-05 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to determine whether using the P3P website can increase decisional preparation and satisfaction, and decrease decisional conflict, in men deciding how to manage early stage prostate cancer.

Enrollment: 392 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Biopsy-proven diagnosis of prostate cancer, T1 or T2 of any risk level
• Biopsy done at enrolling site
• Upcoming appointment with consulting specialist at enrolling study site
• Able to read, write, understand English

Exclusion criteria

• Two or more post-biopsy specialist consults
• Begun treatment (or active surveillance)

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

392 participants in 2 patient groups

Usual patient education + standard educational websites

Other group

Treatment:

Behavioral: Standard prostate cancer information websites

Usual patient education + P3P decision support website

Experimental group

Treatment:

Behavioral: Personal Patient Profile - Prostate (P3P)